Navigation Links
Cequent Names Ted Hibben Chief Business Officer
Date:1/12/2009

colon cancer that causes hundreds of polyps to form in the colon. In addition, Ted will interact with companies that would like to license our technology to deliver therapeutic RNAi for novel metabolic, oncology, or other targets."

Previously, Mr. Hibben served as a senior executive and a corporate and business development consultant for public and private biopharmaceutical companies, including, among others: Centagenetix, Inc., in conjunction with its merger into Elixir Pharmaceuticals, Inc.; Pericor Science, Inc., where he led strategic planning, business operations, and product development for this start-up advancing a novel epithelial drug-delivery technology; and Ontogeny, Inc. (now Curis, Inc.), where he guided Ontogeny's merger with Reprogenesis and Creative Biomolecules. Mr. Hibben has an MBA from Harvard Business School and a bachelor's degree from Dartmouth College.

About Cequent Pharmaceuticals, Inc. (www.cequentpharma.com)

An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human disorders - from inflammatory disease to cancer - based on the company's proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent's first products, now in pre-clinical development, are drug candidates targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful tkRNAi technology to deactivate specific disease-causing genes safely and effectively, using non-pathogenic bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut Pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/Harvard Medical School. A privately held company based in Cambridge, Massachusetts, Cequent was established in 2006. '/>"/>

SOURCE Cequent Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Two Luminaries Join Cequent Scientific Advisory Board: Judy Lieberman, M.D. Ph.D., and Patrice Courvalin, M.D.
2. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
3. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
4. Clarus Ventures Names Two New Partners
5. Xceleron Names Michael Butler as President & CEO
6. Genome Technology Names 2008 Tomorrows PIs
7. Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations
8. USP Names Matthew Heyman Vice President of External Affairs and Strategic Integration
9. LCA-Vision Names Michael J. Celebrezze CFO
10. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
11. Great Basin Scientific, Inc. Names Laurence Rea as Vice President of Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... (PRWEB) August 29, 2014 The ... $5.6 billion in 2019. It is expected to ... to 2019, and was valued at $1.8 billion ... by Transparency Market Research. , For more information ... http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, titled “Companion ...
(Date:8/29/2014)... August 29, 2014 According to a new ... the global orthobiologics market was valued at USD 3,754.6 million ... USD 5,519.9million in 2019at a CAGR of 5.9% from 2013 ... years and above is afflicted by bone and joint disorders, ... year 2020. This has and will continue to increase the ...
(Date:8/29/2014)... 2014 Pittcon is pleased to announce ... Koichiro Matsuda, Horiba Scientific, have organized a session on ... JASIS , Asia’s largest analytical and scientific instruments ... Messe, Japan. , The four speakers in this ... Single Molecules to Single Cells” will present their use ...
(Date:8/29/2014)... 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or ... financial results for the six months ended June ... in Canadian dollars and presented under International Financial ... Highlights , Announced top-line results related ... endpoint for subjects enrolled in the Phase 2 ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4
... YORK, Aug. 31, 2011 Hadasit Bio-Holdings, Ltd. - ... biotech companies, all based on intellectual property developed and ... center, announced today that its CEO, Mr. Ophir Shahaf, ... Investment Conference in New York City on Tuesday, September ...
... DIEGO, Aug. 31, 2011 BioMed Realty Trust, Inc. ... that holders of the 4.50% Exchangeable Senior Notes due ... partnership, BioMed Realty, L.P. (the "Operating Partnership"), which are ... right to surrender their Notes for purchase by the ...
... Aug. 30, 2011 Savvier consumers and competition from ... entry or during brand maturity, more elusive.  At the ... of cost-efficient Public Relations to support pharmaceutical brand growth. ... Relations to support their brands, recent field research from ...
Cached Biology Technology:Hadasit to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13, 2011 2BioMed Realty Announces Repurchase at Option of Holders and Redemption of 4.50% Exchangeable Senior Notes Due 2026 2BioMed Realty Announces Repurchase at Option of Holders and Redemption of 4.50% Exchangeable Senior Notes Due 2026 3BioMed Realty Announces Repurchase at Option of Holders and Redemption of 4.50% Exchangeable Senior Notes Due 2026 4BioMed Realty Announces Repurchase at Option of Holders and Redemption of 4.50% Exchangeable Senior Notes Due 2026 5Using Public Relations to Launch, Grow, and Extend Pharmaceutical and Biotech Brands 2
(Date:8/29/2014)... available in German . ... the natural nitrogen cycle on Earth and in biological ... thought to depend on nitrite as their source of ... Daims, a microbiologist at the University of Vienna, has ... an alternative source of energy. The oxidation of hydrogen ...
(Date:8/29/2014)... . The ... oldest form of communication. Acting as messenger molecules, pheromones ... attraction between males and females. Fish rely on pheromones ... in males and females. Scientists at the Marine Science ... Portugal, and at the Max Planck Institute for Chemical ...
(Date:8/29/2014)... such as the prolific bloomer Emiliania huxleyi , ... discovered. The finding contradicts the common view that ... on scarce supplies of thiamine in the ocean to ... about the ocean," says CIFAR Senior Fellow Alexandra ... paper with CIFAR fellows John Archibald (Dalhousie ...
Breaking Biology News(10 mins):Hydrogen powers important nitrogen-transforming bacteria 2Hydrogen powers important nitrogen-transforming bacteria 3Ready for mating at the right time 2Ready for mating at the right time 3Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3
... make the spread of deadly strains of avian flu ... Edinburgh and Warwick have found. The research shows that ... birds, the disease is likely to spread unless almost ... published in Nature journal, is the first to quantify ...
... transplants of embryonic stem cell-derived motor neurons in ... partially restore function in paralyzed animals. The study ... treating such disorders as spinal cord injury, transverse ... atrophy. The study was funded in part by ...
... cultured in the laboratory during in vitro fertilisation ... with certain developmental syndromes and other abnormalities in ... , Researchers told the 22nd annual conference of ... today (Monday) that preliminary work investigating genetic imprinting ...
Cached Biology News:Bird flu study highlights need to vaccinate flocks effectively 2Neurons grown from embryonic stem cells restore function in paralyzed rats 2Neurons grown from embryonic stem cells restore function in paralyzed rats 3Neurons grown from embryonic stem cells restore function in paralyzed rats 4How IVF could be causing genetic errors in embryos 2How IVF could be causing genetic errors in embryos 3